MedCity News November 11, 2024
Matt Manning

Top challenges impacting specialty pharmacy outcomes, and how health systems may achieve efficiencies and enhance performance for optimal outcomes.

Specialty medications are estimated to comprise 65% of drug spending by 2025, and health systems are rapidly addressing new industry demands with in-house programs to support high-cost, high-touch drug dispensing.

While entity-owned specialty pharmacies meet a clear need for patients requiring complex therapies, getting these programs up and running is only part of the battle. Without strategic optimization across integrated channels, a specialty pharmacy’s long-term success hangs in the balance, but determining how to approach this endeavor often leaves health systems stumped.

Let’s explore the top challenges impacting specialty pharmacy outcomes, and how health systems may achieve efficiencies and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Pharma At A Crossroads: Navigating Cost Pressures And Regulatory Shifts In 2025
Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers
Why Walgreens Is Reportedly Considering a Private Equity Buyer
Why 2025 Could Be A Good Reimbursement Year For CVS And Walgreens

Share This Article